Opsens - OPS Stock Forecast, Price & News

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for industrial applications. The company offers OptoWire, an advanced optical-based pressure guidewire that enhances the clinical outcome of patients with coronary artery disease; and OptoMonitor. It also provides fiber optic temperature sensors, pressure sensors, strain sensors, displacement sensors, and extensometers, as well as signal conditioners/OEM boards. It serves various markets, such as life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. The company is headquartered in Québec, Canada.

Opsens Price Performance

TSE:OPS traded down C$0.04 on Friday, reaching C$2.55. 23,710 shares of the stock traded hands, compared to its average volume of 136,150. The firm's fifty day simple moving average is C$2.31 and its 200 day simple moving average is C$2.09. The company has a quick ratio of 4.88, a current ratio of 5.87 and a debt-to-equity ratio of 18.46. The company has a market cap of C$277.37 million and a price-to-earnings ratio of -43.90. Opsens has a 12 month low of C$1.55 and a 12 month high of C$3.74.

Opsens (TSE:OPS - Get Rating) last issued its quarterly earnings results on Thursday, July 14th. The company reported C($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of C($0.02) by C($0.01). The business had revenue of C$10.08 million during the quarter, compared to analysts' expectations of C$8.65 million. As a group, research analysts predict that Opsens will post -0.06 EPS for the current fiscal year.